Ausgabe Sonderheft 3/2003
Inhalt (10 Artikel)
Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis
Ego Seeman
Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis
P. J. Meunier, J. Y. Reginster
Bone matrix proteins: their function, regulation, and relationship to osteoporosis
Marian F. Young
Is the calcium receptor a molecular target for the actions of strontium on bone?
Edward M. Brown
Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate
P. J. Marie
The mineralization of bone tissue: a forgotten dimension in osteoporosis research
G. Boivin, P. J. Meunier
Assessment of prevalent and incident vertebral fractures in osteoporosis research
H. K. Genant, M. Jergas
Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies
J. Y. Reginster, P. J. Meunier